Literature DB >> 21253118

Acute leukemia: diagnosis, management, and potential for cure.

K Stewart, A Keating.   

Abstract

Acute leukemia is an uncommon malignant disorder resulting from the clonal proliferation of hematopoietic precursors of the myeloid or lymphoid lineages. Of the two major subgroups, acute lymphoblastic leukemia is more common in children, while acute myelogenous leukemia predominates in adults. With modern chemotherapy 60%-70% of all children with acute lymphoblastic leukemia can be long-term survivors and are potentially cured. Although the prognosis in acute myelogenous leukemia is less favourable, recent therapy, including bone-marrow transplantation, offers possible cure in selected patient groups.

Entities:  

Year:  1988        PMID: 21253118      PMCID: PMC2219001     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.

Authors:  A M Yeager; H Kaizer; G W Santos; R Saral; O M Colvin; R K Stuart; H G Braine; P J Burke; R F Ambinder; W H Burns
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

2.  Improved results of treatment of adult acute lymphoblastic leukemia.

Authors:  C A Linker; L J Levitt; M O'Donnell; C A Ries; M P Link; S J Forman; M J Farbstein
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

Review 3.  Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.

Authors:  R Champlin; R P Gale
Journal:  Semin Hematol       Date:  1987-01       Impact factor: 3.851

4.  Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

Authors:  J H Kersey; D Weisdorf; M E Nesbit; T W LeBien; W G Woods; P B McGlave; T Kim; D A Vallera; A I Goldman; B Bostrom
Journal:  N Engl J Med       Date:  1987-08-20       Impact factor: 91.245

5.  Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.

Authors:  P G Steinherz; P Gaynon; D R Miller; G Reaman; A Bleyer; J Finklestein; R G Evans; P Meyers; L J Steinherz; H Sather
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

6.  High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.

Authors:  S N Wolff; R H Herzig; G L Phillips; H M Lazarus; J P Greer; R S Stein; W A Ray; G P Herzig
Journal:  Semin Oncol       Date:  1987-06       Impact factor: 4.929

7.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

8.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia.

Authors:  C D Bloomfield; A I Goldman; G Alimena; R Berger; G H Borgström; L Brandt; D Catovsky; A de la Chapelle; G W Dewald; O M Garson
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

9.  High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia.

Authors:  J J Yunis; R D Brunning; R B Howe; M Lobell
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.